Brief: Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement With Sagard Healthcare Partners
31/10/2022 11:46
Oct 31 (Reuters) - Marinus Pharmaceuticals Inc MRNS.O :
* MARINUS PHARMACEUTICALS ANNOUNCES $32.5 MILLION REVENUE
INTEREST
FINANCING AGREEMENT WITH SAGARD HEALTHCARE PARTNERS
* MARINUS PHARMACEUTICALS INC - $32.5 MILLION OF
NON-DILUTIVE
CAPITAL IS EXPECTED TO PROVIDE A MEANINGFUL EXTENSION OF OUR
CASH RUNWAY INTO Q1 OF 2024
Source text for Eikon: ID:nBw3stQRCa
Further company coverage: MRNS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Marinus Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa
Brief: Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Appfolio, S&P Global, Uber
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group